YALÇIN, B. Et Al. 2002. A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study.. Proceedings of European Society of Clinical Oncology .

YALÇIN, B., ÜNER, A., AKBULUT, H., İÇLİ, F., IŞIKDOĞAN, A., BÜYÜKÇELİK, A., ... DİNÇOL, D.(2002). A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study. . Proceedings of European Society of Clinical Oncology

YALÇIN, BÜLENT Et Al. "A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study.," Proceedings of European Society of Clinical Oncology, 2002

YALÇIN, BÜLENT Et Al. "A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study.." Proceedings of European Society of Clinical Oncology , 2002

YALÇIN, B. Et Al. (2002) . "A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study.." Proceedings of European Society of Clinical Oncology .

@conferencepaper{conferencepaper, author={BÜLENT YALÇIN Et Al. }, title={A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study.}, congress name={Proceedings of European Society of Clinical Oncology}, city={}, country={}, year={2002}}